133 related articles for article (PubMed ID: 38110028)
21. The Use of Ovarian Vein Sampling to Lateralize a Virilizing Leydig Cell Ovarian Tumor.
Baweja K; Shuster S; Awad S
AACE Clin Case Rep; 2023; 9(6):182-185. PubMed ID: 38045790
[TBL] [Abstract][Full Text] [Related]
22. Virilization due to androgen hypersecretion in a patient with ovarian leydig cell tumor: diagnostic and psychosocial implications.
Juniarto AZ; Setiawati BA; Ediati A; van der Zwan YG; Looijenga LH; de Jong FH; Dessens A; Drop SL; Faradz SM
Acta Med Indones; 2013 Apr; 45(2):130-5. PubMed ID: 23770793
[TBL] [Abstract][Full Text] [Related]
23. Postmenopausal hyperandrogenism caused by a benign cystic teratoma: a case report.
Wu DH; McMurtrie DG; Hirsch SD; Johnston CM
J Reprod Med; 2008 Feb; 53(2):141-4. PubMed ID: 18357809
[TBL] [Abstract][Full Text] [Related]
24. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
25. Juvenile Granulosa Cell Tumor Mimicking HAIR-AN in a 4-year-old: A Case Report.
Kim RC; Goldberg I; Van Brunt T; Tul-Bushra H; Batiste R; Lane AH; Hsieh H
J Clin Res Pediatr Endocrinol; 2024 May; 16(2):200-204. PubMed ID: 36112066
[TBL] [Abstract][Full Text] [Related]
26. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
Palha A; Cortez L; Tavares AP; Agapito A
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
[TBL] [Abstract][Full Text] [Related]
27. The Masquerading, Masculinizing Tumor: A Case Report and Review of the Literature.
LeVee A; Suppogu N; Walsh C; Sacks W; Simon J; Shufelt C
J Womens Health (Larchmt); 2021 Jul; 30(7):1047-1051. PubMed ID: 32991246
[TBL] [Abstract][Full Text] [Related]
28. Occult symptomatic bilateral pure Leydig cell tumors in a postmenopausal woman: a case report.
Hussain SA; Dubil EA; De Luca-Johnson JN; Johnston M
Gynecol Endocrinol; 2021 Jul; 37(7):672-675. PubMed ID: 34137345
[TBL] [Abstract][Full Text] [Related]
29. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
[TBL] [Abstract][Full Text] [Related]
30. Virilizing leydig-sertoli cell ovarian tumor associated with endometrioid carcinoma of the endometrium in a postmenopausal patient: case report and general considerations.
Di Giacinto P; Chioma L; Vancieri G; Guccione L; Cicerone E; Ulisse S; Mariani S; Autore C; Fabbri A; Gnessi L; Moretti C
Clin Med Insights Case Rep; 2012; 5():149-53. PubMed ID: 23133317
[TBL] [Abstract][Full Text] [Related]
31. Androgen-Secreting Ovarian Tumors.
Macut D; Ilić D; Mitrović Jovanović A; Bjekić-Macut J
Front Horm Res; 2019; 53():100-107. PubMed ID: 31499493
[TBL] [Abstract][Full Text] [Related]
32. A premenopausal woman with virilization secondary to an ovarian Leydig cell tumor.
Faria AM; Perez RV; Marcondes JA; Freire DS; Blasbalg R; Soares J; Simões K; Hayashida SA; Pereira MA
Nat Rev Endocrinol; 2011 Apr; 7(4):240-5. PubMed ID: 21321567
[TBL] [Abstract][Full Text] [Related]
33. [A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary].
Marcelino M; Nobre E; Conceição J; Lopes L; Vilar H; França Martins M; Carvalho A; André S; Horta A; De Castro JJ
Acta Med Port; 2010; 23(1):113-8. PubMed ID: 20353714
[TBL] [Abstract][Full Text] [Related]
34. Bilateral Ovarian Leydig Cell Tumors in a Postmenopausal Woman Causing Hirsutism and Virilization.
Shakir MKM; Snitchler AN; Vietor NO; Mai VQ; Hoang TD
AACE Clin Case Rep; 2021; 7(1):26-28. PubMed ID: 33851015
[TBL] [Abstract][Full Text] [Related]
35. Ovarian Sertoli-Leydig cell tumours: How typical is their typical presentation?
Melero Cortés LM; Martínez Maestre MÁ; Vieites Pérez-Quintela MB; Gambadauro P
J Obstet Gynaecol; 2017 Jul; 37(5):655-659. PubMed ID: 28485183
[TBL] [Abstract][Full Text] [Related]
36. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
37. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
Taylor HC; Pillay I; Setrakian S
Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
[TBL] [Abstract][Full Text] [Related]
38. Virilizing ovarian hilus (Leydig) cell tumor with concurrent contralateral hilus cell hyperplasia: a rare diagnosis.
Zafrakas M; Venizelos ID; Theodoridis TD; Zepiridis L; Agorastos T; Bontis JN
Eur J Gynaecol Oncol; 2009; 30(3):338-40. PubMed ID: 19697637
[TBL] [Abstract][Full Text] [Related]
39. Hyperandrogenism in a Postmenopausal Woman Secondary to Testosterone Secreting Ovarian Stromal Tumor with Acoustic Schwannoma.
Gandrapu B; Sundar P; Phillips B
Case Rep Endocrinol; 2018; 2018():8154513. PubMed ID: 30627458
[TBL] [Abstract][Full Text] [Related]
40. A case of postmenopausal androgen excess.
Lambrinoudaki I; Dafnios N; Kondi-Pafiti A; Triantafyllou N; Karopoulou E; Papageorgiou A; Augoulea A; Armeni E; Creatsa M; Vlahos N
Gynecol Endocrinol; 2015 Oct; 31(10):760-4. PubMed ID: 26287476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]